BrokerBank Securities Issues its Second Report on PuraMed(TM) BioScience, Inc. Entitled "A Look at the Science Behind This Company's Quest.".SCHOFIELD, Wis. -- PuraMed BioScience, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :PMBS PMBS Packet Mode Bearer Service PMBS Pintle Motion Base Simulator ) a pharmaceutical company engaged in the development and marketing of a line of revolutionary, new, non-prescription medicines targeting major consumer health needs including the treatment of headaches, insomnia insomnia, abnormal wakefulness or inability to sleep. The condition may result from illness or physical discomfort, or it may be caused by stimulants such as coffee or drugs. However, frequently some psychological factor, such as worry or tension, is the cause. and general pain announced today that BrokerBank Securities, Philip Wright, CFA (Computer Fraud and Abuse Act of 1986) Signed into law in 1986, the CFA was a significant step forward in criminalizing unauthorized access to computer systems and networks. The Act applies to "federal interest computers" that include any system used by the U.S. , has published a second report in its investment coverage of PuraMed BioScience, Inc. entitled "A Look at the Science Behind This Company's Quest." The report focuses on the scientific efforts of the company and provides greater detail regarding the enormous markets that each LipiGesic[TM] product addresses. It also provides detailed information on the launch of PuraMed's first product, LipiGesic M for the relief of migraine headaches, and the remarkable opportunity it provides. Russell Mitchell, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , commented on the opportunity the latest report provides, "We are excited to have BrokerBank Securities providing this information to investors and we believe it helps to describe our commitment to building a world-class pharmaceutical enterprise." The full report is available via download at https://brokerbanksecurities.com/ Anyone interested in receiving the report via email or updates regarding PMBS research should e-mail ppwright@brokerbanksecurities.com with "PMBS" in the subject line. BrokerBank Securities Disclosure The analysts contributing to this report do not hold any shares of PuraMed BioScience, Inc. (PMBS). Additionally the analysts contributing to this report certify that the views expressed herein accurately reflect the analysts' personal views as to the subject securities and issuers. The analyst(s) writing this report recognize and aspire to aspire to verb aim for, desire, pursue, hope for, long for, crave, seek out, wish for, dream about, yearn for, hunger for, hanker after, be eager for, set your heart on, set your sights on, be ambitious for all of the CFA Institute The CFA Institute is headquartered in the United States Of America at Charlottesville, Virginia with offices in Hong Kong and London. Formerly known as the Association for Investment Management and Research (AIMR), the Institute awards the prestigious Chartered Financial Analyst Guidelines for Independent Research. BrokerBank Securities ("BrokerBank") certifies that no part of the analysts' compensation was, is, or will be, directly or indirectly, related to the specific recommendation or views expressed by the analysts in the report. This report is based on data obtained from sources we believe to be reliable, but is not guaranteed for accuracy and does not purport to be complete. As such, the report should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed herein are subject to change. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion